Gilead Sciences | The Together Campaign
Together, we can help end the HIV epidemic for everyone, everywhere
Meet our collaborators who make our work possible
Hand in Hand with Mexico & Gilead HIV
A Separate Story About Hope.
When a world-renowned hospital for HIV treatment and prevention was faced with barriers to patient care, one doctor used his voice to improve the quality of care for its future.
Dr. Moussa Seydi worked at Fann Hospital in Senegal for 15 years before rising to become the Head of Infectious and Tropical Diseases. Unfortunately, over this time, the hospital fell into disrepair due to natural disasters. As a leader, his mission was to restore Fann Hospital with new facilities to match their exemplary standards of care.
Gilead and Dr. Seydi had previously combined efforts as a part of the African Society of Infectious Disease, so when Dr. Seydi reached out about his mission, Gilead swiftly supported the cause with a grant to kickstart his project.
With access to more resources and additional support through capturing the attention of the Senegalese government, Dr. Seydi was able to design a new, state-of-the-art facility.
Follow @GileadSciences for updates on this story and more.
Zero Hour™ Podcast
Join us as we explore HIV and health through candid conversations with global health experts, activists, and changemakers.
Zero Hour™ is hosted by Drs. Christopher Chauncey Watson and David Malebranche and produced by Gilead Sciences.
Listen and subscribe on all major podcast platforms or watch on YouTube. Episodes will be available biweekly starting in May 2023.
Ending the epidemic for everyone, everywhere
Decades of scientific innovation, partnership, and advocacy helped transform HIV from a fatal diagnosis to one that could be managed and prevented. Now, we’ll continue to support the wellness of all people impacted by HIV until the virus is eliminated.
We developed the first HIV single tablet regimen and the first oral therapy to prevent HIV, but we’re still researching new strategies.
Advancing equitable care
We’ve forged partnerships to expand access to our life-saving medicines and continue to help facilitate treatment options.
Pervasive prejudice perpetuates stigma surrounding HIV. We’re working closely with communities to fight discrimination.
Gilead’s commitment to ending the epidemic
Where we’ve been
Gilead created the first single-tablet HIV treatment and the first medicines to reduce the risk of infection.1 Gilead is proud to be recognized as the largest private funder of non-profit HIV programs in the U.S., and third largest in the world to date.2
Where we are
We’ve been teaming up with organizations to improve care globally. We’ve launched initiatives like COMPASS, RADIAN®, and Zeroing In™, while growing existing programs like AIDSVu. We are even raising awareness of HIV in Japan with a comic book.
Where we’re headed
We are adapting our approach to HIV treatment and prevention to better support people and communities impacted by the disease. We’re also continuing to fight to end the HIV epidemic, with the goal of achieving a functional cure for HIV.
Voices of Global Health Equity
No Barrier Left Unbroken: Ensuring Health Equity for All
Our vision at Gilead is to ensure worldwide access to equitable care. This starts with understanding the unique barriers that keep people from meaningful, life-changing care. Together with global health experts, we’re reaching across cultures, languages and communities to make sure we end the HIV epidemic for everyone, everywhere.
Gilead is committed to advancing care for patients around the world by bringing forward medicines in areas of unmet medical need. We do this through internal research and development, as well as through collaborations with academic and industry partners.